- Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study. Noone, P.G., Hamblett, N., Accurso, F., Aitken, M.L., Boyle, M., Dovey, M., Gibson, R., Johnson, C., Kellerman, D., Konstan, M.W., Milgram, L., Mundahl, J., Retsch-Bogort, G., Rodman, D., Williams-Warren, J., Wilmott, R.W., Zeitlin, P., Ramsey, B. Pediatr. Pulmonol. (2001)